18 Use of machine learning for dosage individualization of vancomycin in neonates Article Swipe
Bo‐Hao Tang
,
Jinyuan Zhang
,
Karel Allegaert
,
Guo‐Xiang Hao
,
Bu‐Fan Yao
,
Stéphanie Leroux
,
Alison H. Thomson
,
Ze Yu
,
Fei Gao
,
Yi Zheng
,
Yue Zhou
,
Edmund V. Capparelli
,
Valérie Biran
,
Nicolas Simon
,
Bernd Meibohm
,
Yoke Lin Lo
,
Remedios Marqués
,
José‐Esteban Peris
,
Irja Lutsar
,
Jumpei Saito
,
Évelyne Jacqz-Aigrain
,
John van den Anker
,
Yue‐E Wu
,
Wei Zhao
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1136/bmjpo-2024-esdppp.17
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1136/bmjpo-2024-esdppp.17
Introduction High variability in vancomycin exposure in neonates requires advanced individualized dosing regimens. Achieving steady-state trough concentration (C0) and steady-state area-under-curve (AUC0-24) targets are important to optimize treatment. The objective was to evaluate whether machine learning (ML) can be used in clinical practice to predict these treatment targets to calculate optimal individual dosing regimens. Methodology C0 values were retrieved from a large neonatal vancomycin dataset. Individual estimates of AUC0-24 were obtained from Bayesian post-hoc estimation. Various ML algorithms were used for model building to C0 and AUC0-24. An external dataset was used for predictive performance evaluation. Results Before starting treatment, C0 can be predicted a priori using the Catboost-based C0-ML model combined with dosing regimen and 9 covariates. External validation results showed a 42.2% improvement in prediction accuracy by using the ML model compared to the population pharmacokinetic model. The results of the virtual trial showed that using the ML optimised dose, 80.3% of the virtual neonates achieved the pharmacodynamic target (C0 in the range of 10–20 mg/L), much higher than the international standard dose (37.7%-61.5%). Once TDM measurements (C0) in patients have been obtained, AUC0-24 can be further predicted using the Catboost-based AUC-ML model combined with C0 and 9 covariates. External validation results showed that the AUC-ML model can achieve an prediction accuracy of 80.3%. Conclusion C0-based and AUC0-24-based ML models were developed accurately and precisely. These can be used for individual dose recommendation of vancomycin in neonates before treatment and dose revision after the first TDM result is obtained, respectively.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1136/bmjpo-2024-esdppp.17
- https://bmjpaedsopen.bmj.com/content/bmjpo/8/Suppl_6/A8.2.full.pdf
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4401236153
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4401236153Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1136/bmjpo-2024-esdppp.17Digital Object Identifier
- Title
-
18 Use of machine learning for dosage individualization of vancomycin in neonatesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-07-31Full publication date if available
- Authors
-
Bo‐Hao Tang, Jinyuan Zhang, Karel Allegaert, Guo‐Xiang Hao, Bu‐Fan Yao, Stéphanie Leroux, Alison H. Thomson, Ze Yu, Fei Gao, Yi Zheng, Yue Zhou, Edmund V. Capparelli, Valérie Biran, Nicolas Simon, Bernd Meibohm, Yoke Lin Lo, Remedios Marqués, José‐Esteban Peris, Irja Lutsar, Jumpei Saito, Évelyne Jacqz-Aigrain, John van den Anker, Yue‐E Wu, Wei ZhaoList of authors in order
- Landing page
-
https://doi.org/10.1136/bmjpo-2024-esdppp.17Publisher landing page
- PDF URL
-
https://bmjpaedsopen.bmj.com/content/bmjpo/8/Suppl_6/A8.2.full.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://bmjpaedsopen.bmj.com/content/bmjpo/8/Suppl_6/A8.2.full.pdfDirect OA link when available
- Concepts
-
Dosing, Covariate, Therapeutic drug monitoring, Vancomycin, Computer science, Bayesian probability, Population, Machine learning, Pharmacokinetics, Medicine, Artificial intelligence, Pharmacology, Bacteria, Staphylococcus aureus, Genetics, Environmental health, BiologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4401236153 |
|---|---|
| doi | https://doi.org/10.1136/bmjpo-2024-esdppp.17 |
| ids.doi | https://doi.org/10.1136/bmjpo-2024-esdppp.17 |
| ids.openalex | https://openalex.org/W4401236153 |
| fwci | 0.0 |
| type | article |
| title | 18 Use of machine learning for dosage individualization of vancomycin in neonates |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | A9 |
| biblio.first_page | A8.2 |
| topics[0].id | https://openalex.org/T11178 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9873999953269958 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | Receptor Mechanisms and Signaling |
| topics[1].id | https://openalex.org/T12547 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9767000079154968 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2735 |
| topics[1].subfield.display_name | Pediatrics, Perinatology and Child Health |
| topics[1].display_name | Pharmaceutical studies and practices |
| topics[2].id | https://openalex.org/T11016 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9621999859809875 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2741 |
| topics[2].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[2].display_name | Monoclonal and Polyclonal Antibodies Research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2777288759 |
| concepts[0].level | 2 |
| concepts[0].score | 0.7524405717849731 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q4164182 |
| concepts[0].display_name | Dosing |
| concepts[1].id | https://openalex.org/C119043178 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6275166273117065 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q320723 |
| concepts[1].display_name | Covariate |
| concepts[2].id | https://openalex.org/C2780272996 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5529956817626953 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1261151 |
| concepts[2].display_name | Therapeutic drug monitoring |
| concepts[3].id | https://openalex.org/C2778980435 |
| concepts[3].level | 4 |
| concepts[3].score | 0.5121297836303711 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q424027 |
| concepts[3].display_name | Vancomycin |
| concepts[4].id | https://openalex.org/C41008148 |
| concepts[4].level | 0 |
| concepts[4].score | 0.5050163865089417 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[4].display_name | Computer science |
| concepts[5].id | https://openalex.org/C107673813 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4712389409542084 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q812534 |
| concepts[5].display_name | Bayesian probability |
| concepts[6].id | https://openalex.org/C2908647359 |
| concepts[6].level | 2 |
| concepts[6].score | 0.44038888812065125 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[6].display_name | Population |
| concepts[7].id | https://openalex.org/C119857082 |
| concepts[7].level | 1 |
| concepts[7].score | 0.40410274267196655 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q2539 |
| concepts[7].display_name | Machine learning |
| concepts[8].id | https://openalex.org/C112705442 |
| concepts[8].level | 2 |
| concepts[8].score | 0.39372098445892334 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q323936 |
| concepts[8].display_name | Pharmacokinetics |
| concepts[9].id | https://openalex.org/C71924100 |
| concepts[9].level | 0 |
| concepts[9].score | 0.36286139488220215 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[9].display_name | Medicine |
| concepts[10].id | https://openalex.org/C154945302 |
| concepts[10].level | 1 |
| concepts[10].score | 0.287508100271225 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11660 |
| concepts[10].display_name | Artificial intelligence |
| concepts[11].id | https://openalex.org/C98274493 |
| concepts[11].level | 1 |
| concepts[11].score | 0.14041313529014587 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[11].display_name | Pharmacology |
| concepts[12].id | https://openalex.org/C523546767 |
| concepts[12].level | 2 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q10876 |
| concepts[12].display_name | Bacteria |
| concepts[13].id | https://openalex.org/C2779489039 |
| concepts[13].level | 3 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q188121 |
| concepts[13].display_name | Staphylococcus aureus |
| concepts[14].id | https://openalex.org/C54355233 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[14].display_name | Genetics |
| concepts[15].id | https://openalex.org/C99454951 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[15].display_name | Environmental health |
| concepts[16].id | https://openalex.org/C86803240 |
| concepts[16].level | 0 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[16].display_name | Biology |
| keywords[0].id | https://openalex.org/keywords/dosing |
| keywords[0].score | 0.7524405717849731 |
| keywords[0].display_name | Dosing |
| keywords[1].id | https://openalex.org/keywords/covariate |
| keywords[1].score | 0.6275166273117065 |
| keywords[1].display_name | Covariate |
| keywords[2].id | https://openalex.org/keywords/therapeutic-drug-monitoring |
| keywords[2].score | 0.5529956817626953 |
| keywords[2].display_name | Therapeutic drug monitoring |
| keywords[3].id | https://openalex.org/keywords/vancomycin |
| keywords[3].score | 0.5121297836303711 |
| keywords[3].display_name | Vancomycin |
| keywords[4].id | https://openalex.org/keywords/computer-science |
| keywords[4].score | 0.5050163865089417 |
| keywords[4].display_name | Computer science |
| keywords[5].id | https://openalex.org/keywords/bayesian-probability |
| keywords[5].score | 0.4712389409542084 |
| keywords[5].display_name | Bayesian probability |
| keywords[6].id | https://openalex.org/keywords/population |
| keywords[6].score | 0.44038888812065125 |
| keywords[6].display_name | Population |
| keywords[7].id | https://openalex.org/keywords/machine-learning |
| keywords[7].score | 0.40410274267196655 |
| keywords[7].display_name | Machine learning |
| keywords[8].id | https://openalex.org/keywords/pharmacokinetics |
| keywords[8].score | 0.39372098445892334 |
| keywords[8].display_name | Pharmacokinetics |
| keywords[9].id | https://openalex.org/keywords/medicine |
| keywords[9].score | 0.36286139488220215 |
| keywords[9].display_name | Medicine |
| keywords[10].id | https://openalex.org/keywords/artificial-intelligence |
| keywords[10].score | 0.287508100271225 |
| keywords[10].display_name | Artificial intelligence |
| keywords[11].id | https://openalex.org/keywords/pharmacology |
| keywords[11].score | 0.14041313529014587 |
| keywords[11].display_name | Pharmacology |
| language | en |
| locations[0].id | doi:10.1136/bmjpo-2024-esdppp.17 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | |
| locations[0].pdf_url | https://bmjpaedsopen.bmj.com/content/bmjpo/8/Suppl_6/A8.2.full.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | proceedings-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | H) Session 10: Innovative Tools in Clinical Pharmacology II: The FAIR Principle in Clinical Pharmacology |
| locations[0].landing_page_url | https://doi.org/10.1136/bmjpo-2024-esdppp.17 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5072879488 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-9322-4438 |
| authorships[0].author.display_name | Bo‐Hao Tang |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I154099455 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China |
| authorships[0].institutions[0].id | https://openalex.org/I154099455 |
| authorships[0].institutions[0].ror | https://ror.org/0207yh398 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I154099455 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Shandong University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Bo-Hao Tang |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China |
| authorships[1].author.id | https://openalex.org/A5100677997 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-0524-201X |
| authorships[1].author.display_name | Jinyuan Zhang |
| authorships[1].affiliations[0].raw_affiliation_string | Beijing Medicinovo Technology Co. Ltd., Beijing, China |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Jin-Yuan Zhang |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Beijing Medicinovo Technology Co. Ltd., Beijing, China |
| authorships[2].author.id | https://openalex.org/A5088986004 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-9921-5105 |
| authorships[2].author.display_name | Karel Allegaert |
| authorships[2].countries | BE, NL |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I99464096 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Development and Regeneration, KU Leuven, Leuven, Belgium |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I99464096 |
| authorships[2].affiliations[1].raw_affiliation_string | Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium |
| authorships[2].affiliations[2].institution_ids | https://openalex.org/I2801952686, https://openalex.org/I913958620 |
| authorships[2].affiliations[2].raw_affiliation_string | Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands |
| authorships[2].institutions[0].id | https://openalex.org/I99464096 |
| authorships[2].institutions[0].ror | https://ror.org/05f950310 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I99464096 |
| authorships[2].institutions[0].country_code | BE |
| authorships[2].institutions[0].display_name | KU Leuven |
| authorships[2].institutions[1].id | https://openalex.org/I2801952686 |
| authorships[2].institutions[1].ror | https://ror.org/018906e22 |
| authorships[2].institutions[1].type | healthcare |
| authorships[2].institutions[1].lineage | https://openalex.org/I2801952686 |
| authorships[2].institutions[1].country_code | NL |
| authorships[2].institutions[1].display_name | Erasmus MC |
| authorships[2].institutions[2].id | https://openalex.org/I913958620 |
| authorships[2].institutions[2].ror | https://ror.org/057w15z03 |
| authorships[2].institutions[2].type | education |
| authorships[2].institutions[2].lineage | https://openalex.org/I913958620 |
| authorships[2].institutions[2].country_code | NL |
| authorships[2].institutions[2].display_name | Erasmus University Rotterdam |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Karel Allegaert |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Development and Regeneration, KU Leuven, Leuven, Belgium, Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium |
| authorships[3].author.id | https://openalex.org/A5048633875 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Guo‐Xiang Hao |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I154099455 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China |
| authorships[3].institutions[0].id | https://openalex.org/I154099455 |
| authorships[3].institutions[0].ror | https://ror.org/0207yh398 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I154099455 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Shandong University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Guo-Xiang Hao |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China |
| authorships[4].author.id | https://openalex.org/A5029098505 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-8344-6520 |
| authorships[4].author.display_name | Bu‐Fan Yao |
| authorships[4].countries | CN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I154099455 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China |
| authorships[4].institutions[0].id | https://openalex.org/I154099455 |
| authorships[4].institutions[0].ror | https://ror.org/0207yh398 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I154099455 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | Shandong University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Bu-Fan Yao |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China |
| authorships[5].author.id | https://openalex.org/A5102858873 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-2727-5269 |
| authorships[5].author.display_name | Stéphanie Leroux |
| authorships[5].countries | FR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210155724 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Pediatrics, CHU de Rennes, Rennes, France |
| authorships[5].institutions[0].id | https://openalex.org/I4210155724 |
| authorships[5].institutions[0].ror | https://ror.org/05qec5a53 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210155724 |
| authorships[5].institutions[0].country_code | FR |
| authorships[5].institutions[0].display_name | Centre Hospitalier Universitaire de Rennes |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Stephanie Leroux |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Pediatrics, CHU de Rennes, Rennes, France |
| authorships[6].author.id | https://openalex.org/A5045334477 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-2354-6116 |
| authorships[6].author.display_name | Alison H. Thomson |
| authorships[6].countries | GB |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I181647926 |
| authorships[6].affiliations[0].raw_affiliation_string | Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK |
| authorships[6].institutions[0].id | https://openalex.org/I181647926 |
| authorships[6].institutions[0].ror | https://ror.org/00n3w3b69 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I181647926 |
| authorships[6].institutions[0].country_code | GB |
| authorships[6].institutions[0].display_name | University of Strathclyde |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Alison H Thomson |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK |
| authorships[7].author.id | https://openalex.org/A5061309381 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-4727-8427 |
| authorships[7].author.display_name | Ze Yu |
| authorships[7].affiliations[0].raw_affiliation_string | Beijing Medicinovo Technology Co. Ltd., Beijing, China |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Ze Yu |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Beijing Medicinovo Technology Co. Ltd., Beijing, China |
| authorships[8].author.id | https://openalex.org/A5001383535 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-4678-1936 |
| authorships[8].author.display_name | Fei Gao |
| authorships[8].affiliations[0].raw_affiliation_string | Beijing Medicinovo Technology Co. Ltd., Beijing, China |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Fei Gao |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Beijing Medicinovo Technology Co. Ltd., Beijing, China |
| authorships[9].author.id | https://openalex.org/A5083133102 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-0193-1213 |
| authorships[9].author.display_name | Yi Zheng |
| authorships[9].countries | CN |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I154099455 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China |
| authorships[9].institutions[0].id | https://openalex.org/I154099455 |
| authorships[9].institutions[0].ror | https://ror.org/0207yh398 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I154099455 |
| authorships[9].institutions[0].country_code | CN |
| authorships[9].institutions[0].display_name | Shandong University |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Yi Zheng |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China |
| authorships[10].author.id | https://openalex.org/A5101047308 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Yue Zhou |
| authorships[10].countries | CN |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I154099455 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China |
| authorships[10].institutions[0].id | https://openalex.org/I154099455 |
| authorships[10].institutions[0].ror | https://ror.org/0207yh398 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I154099455 |
| authorships[10].institutions[0].country_code | CN |
| authorships[10].institutions[0].display_name | Shandong University |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Yue Zhou |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China |
| authorships[11].author.id | https://openalex.org/A5040076878 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-1630-0505 |
| authorships[11].author.display_name | Edmund V. Capparelli |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I36258959 |
| authorships[11].affiliations[0].raw_affiliation_string | Pediatric Pharmacology and Drug Discovery, University of California, San Diego, CA, USA |
| authorships[11].institutions[0].id | https://openalex.org/I36258959 |
| authorships[11].institutions[0].ror | https://ror.org/0168r3w48 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I36258959 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | University of California, San Diego |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Edmund V Capparelli |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Pediatric Pharmacology and Drug Discovery, University of California, San Diego, CA, USA |
| authorships[12].author.id | https://openalex.org/A5011994701 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-0284-3103 |
| authorships[12].author.display_name | Valérie Biran |
| authorships[12].countries | FR |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210126712 |
| authorships[12].affiliations[0].raw_affiliation_string | Neonatal Intensive Care Unit, Hospital Robert Debre, Paris, France |
| authorships[12].institutions[0].id | https://openalex.org/I4210126712 |
| authorships[12].institutions[0].ror | https://ror.org/02dcqy320 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210126712 |
| authorships[12].institutions[0].country_code | FR |
| authorships[12].institutions[0].display_name | Hôpital Robert-Debré |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Valerie Biran |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Neonatal Intensive Care Unit, Hospital Robert Debre, Paris, France |
| authorships[13].author.id | https://openalex.org/A5063118702 |
| authorships[13].author.orcid | https://orcid.org/0000-0003-4393-2257 |
| authorships[13].author.display_name | Nicolas Simon |
| authorships[13].countries | FR |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I4210134195, https://openalex.org/I4210159661, https://openalex.org/I4210166444 |
| authorships[13].affiliations[0].raw_affiliation_string | Aix Marseille Univ, APHM, INSERM, IRD, SESSTIM, Hop Sainte Marguerite, Service de Pharmacologie Clinique, CAP-TV, Marseille, France |
| authorships[13].institutions[0].id | https://openalex.org/I4210159661 |
| authorships[13].institutions[0].ror | https://ror.org/0508wny29 |
| authorships[13].institutions[0].type | facility |
| authorships[13].institutions[0].lineage | https://openalex.org/I154526488, https://openalex.org/I21491767, https://openalex.org/I2802818602, https://openalex.org/I4210090127, https://openalex.org/I4210111578, https://openalex.org/I4210131494, https://openalex.org/I4210159661, https://openalex.org/I4210166444 |
| authorships[13].institutions[0].country_code | FR |
| authorships[13].institutions[0].display_name | Economic & Social Sciences, Health Systems & Medical Informatics |
| authorships[13].institutions[1].id | https://openalex.org/I4210134195 |
| authorships[13].institutions[1].ror | https://ror.org/0338wkj94 |
| authorships[13].institutions[1].type | healthcare |
| authorships[13].institutions[1].lineage | https://openalex.org/I4210087487, https://openalex.org/I4210134195 |
| authorships[13].institutions[1].country_code | FR |
| authorships[13].institutions[1].display_name | Hôpital Sainte-Marguerite |
| authorships[13].institutions[2].id | https://openalex.org/I154526488 |
| authorships[13].institutions[2].ror | https://ror.org/02vjkv261 |
| authorships[13].institutions[2].type | government |
| authorships[13].institutions[2].lineage | https://openalex.org/I154526488 |
| authorships[13].institutions[2].country_code | FR |
| authorships[13].institutions[2].display_name | Inserm |
| authorships[13].institutions[3].id | https://openalex.org/I4210166444 |
| authorships[13].institutions[3].ror | https://ror.org/05q3vnk25 |
| authorships[13].institutions[3].type | government |
| authorships[13].institutions[3].lineage | https://openalex.org/I2802818602, https://openalex.org/I4210090127, https://openalex.org/I4210131494, https://openalex.org/I4210166444 |
| authorships[13].institutions[3].country_code | FR |
| authorships[13].institutions[3].display_name | Institut de Recherche pour le Développement |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Nicolas Simon |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Aix Marseille Univ, APHM, INSERM, IRD, SESSTIM, Hop Sainte Marguerite, Service de Pharmacologie Clinique, CAP-TV, Marseille, France |
| authorships[14].author.id | https://openalex.org/A5058057231 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-3923-3648 |
| authorships[14].author.display_name | Bernd Meibohm |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I160606119 |
| authorships[14].affiliations[0].raw_affiliation_string | Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, USA |
| authorships[14].institutions[0].id | https://openalex.org/I160606119 |
| authorships[14].institutions[0].ror | https://ror.org/0011qv509 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I160606119 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | University of Tennessee Health Science Center |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Bernd Meibohm |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, USA |
| authorships[15].author.id | https://openalex.org/A5015575968 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-5521-2543 |
| authorships[15].author.display_name | Yoke Lin Lo |
| authorships[15].countries | MY |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I33849332 |
| authorships[15].affiliations[0].raw_affiliation_string | Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia |
| authorships[15].affiliations[1].institution_ids | https://openalex.org/I62370553 |
| authorships[15].affiliations[1].raw_affiliation_string | School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia |
| authorships[15].institutions[0].id | https://openalex.org/I62370553 |
| authorships[15].institutions[0].ror | https://ror.org/04d4wjw61 |
| authorships[15].institutions[0].type | education |
| authorships[15].institutions[0].lineage | https://openalex.org/I62370553 |
| authorships[15].institutions[0].country_code | MY |
| authorships[15].institutions[0].display_name | International Medical University |
| authorships[15].institutions[1].id | https://openalex.org/I33849332 |
| authorships[15].institutions[1].ror | https://ror.org/00rzspn62 |
| authorships[15].institutions[1].type | education |
| authorships[15].institutions[1].lineage | https://openalex.org/I33849332 |
| authorships[15].institutions[1].country_code | MY |
| authorships[15].institutions[1].display_name | University of Malaya |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Yoke-Lin Lo |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia |
| authorships[16].author.id | https://openalex.org/A5110468834 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Remedios Marqués |
| authorships[16].affiliations[0].raw_affiliation_string | Department of Pharmacy Services, La Fe Hospital, Valencia, Spain |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Remedios Marques |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Department of Pharmacy Services, La Fe Hospital, Valencia, Spain |
| authorships[17].author.id | https://openalex.org/A5070288537 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-4811-239X |
| authorships[17].author.display_name | José‐Esteban Peris |
| authorships[17].countries | ES |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I16097986 |
| authorships[17].affiliations[0].raw_affiliation_string | Department of Pharmacy and Pharmaceutical Technology, University of Valencia, Valencia, Spain |
| authorships[17].institutions[0].id | https://openalex.org/I16097986 |
| authorships[17].institutions[0].ror | https://ror.org/043nxc105 |
| authorships[17].institutions[0].type | education |
| authorships[17].institutions[0].lineage | https://openalex.org/I16097986 |
| authorships[17].institutions[0].country_code | ES |
| authorships[17].institutions[0].display_name | Universitat de València |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Jose-Esteban Peris |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Department of Pharmacy and Pharmaceutical Technology, University of Valencia, Valencia, Spain |
| authorships[18].author.id | https://openalex.org/A5010067946 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-5082-429X |
| authorships[18].author.display_name | Irja Lutsar |
| authorships[18].countries | EE |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I56085075 |
| authorships[18].affiliations[0].raw_affiliation_string | Institute of Medical Microbiology, University of Tartu, Tartu, Estonia |
| authorships[18].institutions[0].id | https://openalex.org/I56085075 |
| authorships[18].institutions[0].ror | https://ror.org/03z77qz90 |
| authorships[18].institutions[0].type | education |
| authorships[18].institutions[0].lineage | https://openalex.org/I56085075 |
| authorships[18].institutions[0].country_code | EE |
| authorships[18].institutions[0].display_name | University of Tartu |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Irja Lutsar |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Institute of Medical Microbiology, University of Tartu, Tartu, Estonia |
| authorships[19].author.id | https://openalex.org/A5058900236 |
| authorships[19].author.orcid | https://orcid.org/0000-0003-4799-5562 |
| authorships[19].author.display_name | Jumpei Saito |
| authorships[19].countries | JP |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I4210132193 |
| authorships[19].affiliations[0].raw_affiliation_string | Department of Pharmacy, National Children's Hospital National Center for Child Health and Development, Tokyo, Japan |
| authorships[19].institutions[0].id | https://openalex.org/I4210132193 |
| authorships[19].institutions[0].ror | https://ror.org/03fvwxc59 |
| authorships[19].institutions[0].type | government |
| authorships[19].institutions[0].lineage | https://openalex.org/I4210132193 |
| authorships[19].institutions[0].country_code | JP |
| authorships[19].institutions[0].display_name | National Center For Child Health and Development |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Jumpei Saito |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Department of Pharmacy, National Children's Hospital National Center for Child Health and Development, Tokyo, Japan |
| authorships[20].author.id | https://openalex.org/A5026079355 |
| authorships[20].author.orcid | https://orcid.org/0000-0002-4285-7067 |
| authorships[20].author.display_name | Évelyne Jacqz-Aigrain |
| authorships[20].countries | FR |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I4210097159 |
| authorships[20].affiliations[0].raw_affiliation_string | Department of Pediatric Pharmacology and Pharmacogenetics, Hospital Robert Debre, APHP, Paris, France |
| authorships[20].affiliations[1].institution_ids | https://openalex.org/I4210126712 |
| authorships[20].affiliations[1].raw_affiliation_string | Clinical Investigation Center CIC1426, Ho^pital Robert Debre´, Paris, France |
| authorships[20].affiliations[2].institution_ids | https://openalex.org/I169173203, https://openalex.org/I204730241, https://openalex.org/I4210091437 |
| authorships[20].affiliations[2].raw_affiliation_string | University Paris Diderot, Sorbonne Paris Cite, Paris, France |
| authorships[20].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[20].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[20].institutions[0].type | healthcare |
| authorships[20].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[20].institutions[0].country_code | FR |
| authorships[20].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[20].institutions[1].id | https://openalex.org/I169173203 |
| authorships[20].institutions[1].ror | https://ror.org/00bw5n526 |
| authorships[20].institutions[1].type | government |
| authorships[20].institutions[1].lineage | https://openalex.org/I154526488, https://openalex.org/I169173203 |
| authorships[20].institutions[1].country_code | FR |
| authorships[20].institutions[1].display_name | Délégation Paris 7 |
| authorships[20].institutions[2].id | https://openalex.org/I4210126712 |
| authorships[20].institutions[2].ror | https://ror.org/02dcqy320 |
| authorships[20].institutions[2].type | healthcare |
| authorships[20].institutions[2].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210126712 |
| authorships[20].institutions[2].country_code | FR |
| authorships[20].institutions[2].display_name | Hôpital Robert-Debré |
| authorships[20].institutions[3].id | https://openalex.org/I4210091437 |
| authorships[20].institutions[3].ror | https://ror.org/001z21q04 |
| authorships[20].institutions[3].type | other |
| authorships[20].institutions[3].lineage | https://openalex.org/I4210091437 |
| authorships[20].institutions[3].country_code | FR |
| authorships[20].institutions[3].display_name | Sorbonne Paris Cité |
| authorships[20].institutions[4].id | https://openalex.org/I204730241 |
| authorships[20].institutions[4].ror | https://ror.org/05f82e368 |
| authorships[20].institutions[4].type | education |
| authorships[20].institutions[4].lineage | https://openalex.org/I204730241 |
| authorships[20].institutions[4].country_code | FR |
| authorships[20].institutions[4].display_name | Université Paris Cité |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Evelyne Jacqz-Aigrain |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Clinical Investigation Center CIC1426, Ho^pital Robert Debre´, Paris, France, Department of Pediatric Pharmacology and Pharmacogenetics, Hospital Robert Debre, APHP, Paris, France, University Paris Diderot, Sorbonne Paris Cite, Paris, France |
| authorships[21].author.id | https://openalex.org/A5049312380 |
| authorships[21].author.orcid | https://orcid.org/0000-0003-0571-7492 |
| authorships[21].author.display_name | John van den Anker |
| authorships[21].countries | CH, US |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I193531525 |
| authorships[21].affiliations[0].raw_affiliation_string | Departments of Pediatrics, Pharmacology and Physiology, Genomics and Precision Medicine, the George Washington University School of Medicine and Health Sciences, Washington, DC, USA |
| authorships[21].affiliations[1].institution_ids | https://openalex.org/I1336742384 |
| authorships[21].affiliations[1].raw_affiliation_string | Division of Clinical Pharmacology, Children's National Hospital, Washington, DC, USA |
| authorships[21].affiliations[2].institution_ids | https://openalex.org/I1850255, https://openalex.org/I4210126115 |
| authorships[21].affiliations[2].raw_affiliation_string | Department of Pediatric Pharmacology and Pharmacometrics, University of Basel Children's Hospital, Basel, Switzerland |
| authorships[21].institutions[0].id | https://openalex.org/I4210126115 |
| authorships[21].institutions[0].ror | https://ror.org/02nhqek82 |
| authorships[21].institutions[0].type | healthcare |
| authorships[21].institutions[0].lineage | https://openalex.org/I4210126115 |
| authorships[21].institutions[0].country_code | CH |
| authorships[21].institutions[0].display_name | University Children’s Hospital Basel |
| authorships[21].institutions[1].id | https://openalex.org/I1850255 |
| authorships[21].institutions[1].ror | https://ror.org/02s6k3f65 |
| authorships[21].institutions[1].type | education |
| authorships[21].institutions[1].lineage | https://openalex.org/I1850255 |
| authorships[21].institutions[1].country_code | CH |
| authorships[21].institutions[1].display_name | University of Basel |
| authorships[21].institutions[2].id | https://openalex.org/I1336742384 |
| authorships[21].institutions[2].ror | https://ror.org/03wa2q724 |
| authorships[21].institutions[2].type | healthcare |
| authorships[21].institutions[2].lineage | https://openalex.org/I1336742384 |
| authorships[21].institutions[2].country_code | US |
| authorships[21].institutions[2].display_name | Children's National |
| authorships[21].institutions[3].id | https://openalex.org/I193531525 |
| authorships[21].institutions[3].ror | https://ror.org/00y4zzh67 |
| authorships[21].institutions[3].type | education |
| authorships[21].institutions[3].lineage | https://openalex.org/I193531525 |
| authorships[21].institutions[3].country_code | US |
| authorships[21].institutions[3].display_name | George Washington University |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | John van den Anker |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Department of Pediatric Pharmacology and Pharmacometrics, University of Basel Children's Hospital, Basel, Switzerland, Departments of Pediatrics, Pharmacology and Physiology, Genomics and Precision Medicine, the George Washington University School of Medicine and Health Sciences, Washington, DC, USA, Division of Clinical Pharmacology, Children's National Hospital, Washington, DC, USA |
| authorships[22].author.id | https://openalex.org/A5102490889 |
| authorships[22].author.orcid | |
| authorships[22].author.display_name | Yue‐E Wu |
| authorships[22].countries | CN |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I154099455 |
| authorships[22].affiliations[0].raw_affiliation_string | Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China |
| authorships[22].institutions[0].id | https://openalex.org/I154099455 |
| authorships[22].institutions[0].ror | https://ror.org/0207yh398 |
| authorships[22].institutions[0].type | education |
| authorships[22].institutions[0].lineage | https://openalex.org/I154099455 |
| authorships[22].institutions[0].country_code | CN |
| authorships[22].institutions[0].display_name | Shandong University |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Yue-E Wu |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China |
| authorships[23].author.id | https://openalex.org/A5012945245 |
| authorships[23].author.orcid | https://orcid.org/0000-0002-4839-6791 |
| authorships[23].author.display_name | Wei Zhao |
| authorships[23].countries | CN |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I4210161528 |
| authorships[23].affiliations[0].raw_affiliation_string | NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, Qilu Hospital of Shandong University, Shandong University, Jinan, China |
| authorships[23].affiliations[1].institution_ids | https://openalex.org/I154099455 |
| authorships[23].affiliations[1].raw_affiliation_string | Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China |
| authorships[23].institutions[0].id | https://openalex.org/I4210161528 |
| authorships[23].institutions[0].ror | https://ror.org/056ef9489 |
| authorships[23].institutions[0].type | healthcare |
| authorships[23].institutions[0].lineage | https://openalex.org/I4210161528 |
| authorships[23].institutions[0].country_code | CN |
| authorships[23].institutions[0].display_name | Qilu Hospital of Shandong University |
| authorships[23].institutions[1].id | https://openalex.org/I154099455 |
| authorships[23].institutions[1].ror | https://ror.org/0207yh398 |
| authorships[23].institutions[1].type | education |
| authorships[23].institutions[1].lineage | https://openalex.org/I154099455 |
| authorships[23].institutions[1].country_code | CN |
| authorships[23].institutions[1].display_name | Shandong University |
| authorships[23].author_position | last |
| authorships[23].raw_author_name | Wei Zhao |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China, NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, Qilu Hospital of Shandong University, Shandong University, Jinan, China |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://bmjpaedsopen.bmj.com/content/bmjpo/8/Suppl_6/A8.2.full.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | 18 Use of machine learning for dosage individualization of vancomycin in neonates |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11178 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9873999953269958 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | Receptor Mechanisms and Signaling |
| related_works | https://openalex.org/W3138397568, https://openalex.org/W4389732869, https://openalex.org/W2902050180, https://openalex.org/W4223534033, https://openalex.org/W1911417339, https://openalex.org/W4221095273, https://openalex.org/W4367175696, https://openalex.org/W4213414504, https://openalex.org/W2378907788, https://openalex.org/W4399325342 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1136/bmjpo-2024-esdppp.17 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://bmjpaedsopen.bmj.com/content/bmjpo/8/Suppl_6/A8.2.full.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | proceedings-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | H) Session 10: Innovative Tools in Clinical Pharmacology II: The FAIR Principle in Clinical Pharmacology |
| best_oa_location.landing_page_url | https://doi.org/10.1136/bmjpo-2024-esdppp.17 |
| primary_location.id | doi:10.1136/bmjpo-2024-esdppp.17 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | |
| primary_location.pdf_url | https://bmjpaedsopen.bmj.com/content/bmjpo/8/Suppl_6/A8.2.full.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | proceedings-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | H) Session 10: Innovative Tools in Clinical Pharmacology II: The FAIR Principle in Clinical Pharmacology |
| primary_location.landing_page_url | https://doi.org/10.1136/bmjpo-2024-esdppp.17 |
| publication_date | 2024-07-31 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index.9 | 116, 199 |
| abstract_inverted_index.a | 60, 104, 122 |
| abstract_inverted_index.An | 87 |
| abstract_inverted_index.C0 | 55, 84, 100, 197 |
| abstract_inverted_index.ML | 76, 131, 149, 220 |
| abstract_inverted_index.an | 211 |
| abstract_inverted_index.be | 38, 102, 187, 229 |
| abstract_inverted_index.by | 128 |
| abstract_inverted_index.in | 3, 6, 40, 125, 162, 180, 237 |
| abstract_inverted_index.is | 249 |
| abstract_inverted_index.of | 67, 141, 153, 165, 214, 235 |
| abstract_inverted_index.to | 25, 31, 43, 48, 83, 134 |
| abstract_inverted_index.(C0 | 161 |
| abstract_inverted_index.TDM | 177, 247 |
| abstract_inverted_index.The | 28, 139 |
| abstract_inverted_index.and | 18, 85, 115, 198, 218, 225, 241 |
| abstract_inverted_index.are | 23 |
| abstract_inverted_index.can | 37, 101, 186, 209, 228 |
| abstract_inverted_index.for | 80, 92, 231 |
| abstract_inverted_index.the | 107, 130, 135, 142, 148, 154, 158, 163, 171, 191, 206, 245 |
| abstract_inverted_index.was | 30, 90 |
| abstract_inverted_index.(C0) | 17, 179 |
| abstract_inverted_index.(ML) | 36 |
| abstract_inverted_index.High | 1 |
| abstract_inverted_index.Once | 176 |
| abstract_inverted_index.been | 183 |
| abstract_inverted_index.dose | 174, 233, 242 |
| abstract_inverted_index.from | 59, 71 |
| abstract_inverted_index.have | 182 |
| abstract_inverted_index.much | 168 |
| abstract_inverted_index.than | 170 |
| abstract_inverted_index.that | 146, 205 |
| abstract_inverted_index.used | 39, 79, 91, 230 |
| abstract_inverted_index.were | 57, 69, 78, 222 |
| abstract_inverted_index.with | 112, 196 |
| abstract_inverted_index.42.2% | 123 |
| abstract_inverted_index.80.3% | 152 |
| abstract_inverted_index.C0-ML | 109 |
| abstract_inverted_index.These | 227 |
| abstract_inverted_index.after | 244 |
| abstract_inverted_index.dose, | 151 |
| abstract_inverted_index.first | 246 |
| abstract_inverted_index.large | 61 |
| abstract_inverted_index.model | 81, 110, 132, 194, 208 |
| abstract_inverted_index.range | 164 |
| abstract_inverted_index.these | 45 |
| abstract_inverted_index.trial | 144 |
| abstract_inverted_index.using | 106, 129, 147, 190 |
| abstract_inverted_index.80.3%. | 215 |
| abstract_inverted_index.AUC-ML | 193, 207 |
| abstract_inverted_index.Before | 97 |
| abstract_inverted_index.before | 239 |
| abstract_inverted_index.dosing | 11, 52, 113 |
| abstract_inverted_index.higher | 169 |
| abstract_inverted_index.mg/L), | 167 |
| abstract_inverted_index.model. | 138 |
| abstract_inverted_index.models | 221 |
| abstract_inverted_index.priori | 105 |
| abstract_inverted_index.result | 248 |
| abstract_inverted_index.showed | 121, 145, 204 |
| abstract_inverted_index.target | 160 |
| abstract_inverted_index.trough | 15 |
| abstract_inverted_index.values | 56 |
| abstract_inverted_index.10–20 | 166 |
| abstract_inverted_index.AUC0-24 | 68, 185 |
| abstract_inverted_index.Various | 75 |
| abstract_inverted_index.achieve | 210 |
| abstract_inverted_index.dataset | 89 |
| abstract_inverted_index.further | 188 |
| abstract_inverted_index.machine | 34 |
| abstract_inverted_index.optimal | 50 |
| abstract_inverted_index.predict | 44 |
| abstract_inverted_index.regimen | 114 |
| abstract_inverted_index.results | 120, 140, 203 |
| abstract_inverted_index.targets | 22, 47 |
| abstract_inverted_index.virtual | 143, 155 |
| abstract_inverted_index.whether | 33 |
| abstract_inverted_index.AUC0-24. | 86 |
| abstract_inverted_index.Bayesian | 72 |
| abstract_inverted_index.C0-based | 217 |
| abstract_inverted_index.External | 118, 201 |
| abstract_inverted_index.accuracy | 127, 213 |
| abstract_inverted_index.achieved | 157 |
| abstract_inverted_index.advanced | 9 |
| abstract_inverted_index.building | 82 |
| abstract_inverted_index.clinical | 41 |
| abstract_inverted_index.combined | 111, 195 |
| abstract_inverted_index.compared | 133 |
| abstract_inverted_index.dataset. | 64 |
| abstract_inverted_index.evaluate | 32 |
| abstract_inverted_index.exposure | 5 |
| abstract_inverted_index.external | 88 |
| abstract_inverted_index.learning | 35 |
| abstract_inverted_index.neonatal | 62 |
| abstract_inverted_index.neonates | 7, 156, 238 |
| abstract_inverted_index.obtained | 70 |
| abstract_inverted_index.optimize | 26 |
| abstract_inverted_index.patients | 181 |
| abstract_inverted_index.post-hoc | 73 |
| abstract_inverted_index.practice | 42 |
| abstract_inverted_index.requires | 8 |
| abstract_inverted_index.revision | 243 |
| abstract_inverted_index.standard | 173 |
| abstract_inverted_index.starting | 98 |
| abstract_inverted_index.(AUC0-24) | 21 |
| abstract_inverted_index.Achieving | 13 |
| abstract_inverted_index.calculate | 49 |
| abstract_inverted_index.developed | 223 |
| abstract_inverted_index.estimates | 66 |
| abstract_inverted_index.important | 24 |
| abstract_inverted_index.objective | 29 |
| abstract_inverted_index.obtained, | 184, 250 |
| abstract_inverted_index.optimised | 150 |
| abstract_inverted_index.predicted | 103, 189 |
| abstract_inverted_index.regimens. | 12, 53 |
| abstract_inverted_index.retrieved | 58 |
| abstract_inverted_index.treatment | 46, 240 |
| abstract_inverted_index.Individual | 65 |
| abstract_inverted_index.accurately | 224 |
| abstract_inverted_index.algorithms | 77 |
| abstract_inverted_index.individual | 51, 232 |
| abstract_inverted_index.population | 136 |
| abstract_inverted_index.precisely. | 226 |
| abstract_inverted_index.prediction | 126, 212 |
| abstract_inverted_index.predictive | 93 |
| abstract_inverted_index.treatment, | 99 |
| abstract_inverted_index.treatment. | 27 |
| abstract_inverted_index.validation | 119, 202 |
| abstract_inverted_index.vancomycin | 4, 63, 236 |
| abstract_inverted_index.covariates. | 117, 200 |
| abstract_inverted_index.estimation. | 74 |
| abstract_inverted_index.evaluation. | 95 |
| abstract_inverted_index.improvement | 124 |
| abstract_inverted_index.performance | 94 |
| abstract_inverted_index.variability | 2 |
| abstract_inverted_index.measurements | 178 |
| abstract_inverted_index.steady-state | 14, 19 |
| abstract_inverted_index.AUC0-24-based | 219 |
| abstract_inverted_index.concentration | 16 |
| abstract_inverted_index.international | 172 |
| abstract_inverted_index.respectively. | 251 |
| abstract_inverted_index.(37.7%-61.5%). | 175 |
| abstract_inverted_index.Catboost-based | 108, 192 |
| abstract_inverted_index.individualized | 10 |
| abstract_inverted_index.recommendation | 234 |
| abstract_inverted_index.pharmacodynamic | 159 |
| abstract_inverted_index.pharmacokinetic | 137 |
| abstract_inverted_index.<h3>Results</h3> | 96 |
| abstract_inverted_index.area-under-curve | 20 |
| abstract_inverted_index.<h3>Conclusion</h3> | 216 |
| abstract_inverted_index.<h3>Methodology</h3> | 54 |
| abstract_inverted_index.<h3>Introduction</h3> | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 11 |
| institutions_distinct_count | 24 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/5 |
| sustainable_development_goals[0].score | 0.4099999964237213 |
| sustainable_development_goals[0].display_name | Gender equality |
| citation_normalized_percentile.value | 0.13819398 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |